JPS51121511A - Production of vaccine based on polysaccharid adduct nucleotic acid extracted from microorganism bacterium - Google Patents

Production of vaccine based on polysaccharid adduct nucleotic acid extracted from microorganism bacterium

Info

Publication number
JPS51121511A
JPS51121511A JP51034585A JP3458576A JPS51121511A JP S51121511 A JPS51121511 A JP S51121511A JP 51034585 A JP51034585 A JP 51034585A JP 3458576 A JP3458576 A JP 3458576A JP S51121511 A JPS51121511 A JP S51121511A
Authority
JP
Japan
Prior art keywords
polysaccharid
adduct
production
acid extracted
vaccine based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51034585A
Other languages
English (en)
Japanese (ja)
Inventor
Deyusuuru Danteruran Rushiyan
Norumie Jieraaru
Marii Bineru Annu
Seeru Yuuberu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Publication of JPS51121511A publication Critical patent/JPS51121511A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP51034585A 1975-04-02 1976-03-31 Production of vaccine based on polysaccharid adduct nucleotic acid extracted from microorganism bacterium Pending JPS51121511A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7510252A FR2305990A1 (fr) 1975-04-02 1975-04-02 Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens

Publications (1)

Publication Number Publication Date
JPS51121511A true JPS51121511A (en) 1976-10-23

Family

ID=9153417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51034585A Pending JPS51121511A (en) 1975-04-02 1976-03-31 Production of vaccine based on polysaccharid adduct nucleotic acid extracted from microorganism bacterium

Country Status (6)

Country Link
JP (1) JPS51121511A (enExample)
BE (1) BE839893A (enExample)
DE (1) DE2613943C3 (enExample)
ES (1) ES446637A1 (enExample)
FR (1) FR2305990A1 (enExample)
GB (1) GB1543962A (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2253499B1 (enExample) * 1973-12-10 1977-11-04 Fabre Sa Pierre
FR2444464A1 (fr) 1978-12-19 1980-07-18 Fabre Sa Pierre Proteoglycanes bacteriens purifies, procede pour leur preparation et vaccin les contenant
FR2471785A1 (fr) * 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
FR2596064B1 (fr) * 1986-03-18 1990-02-02 Pf Medicament Procedes industriels de fabrication de vaccins ribosomaux et vaccins ribosomaux obtenus
AR055311A1 (es) 2006-02-17 2007-08-15 H P B S A Composicion farmaceutica solida para el tratamiento de la hiperplasia benigna de prostata, procedimiento para su elaboracion y metodo de tratamiento

Also Published As

Publication number Publication date
GB1543962A (en) 1979-04-11
BE839893A (fr) 1976-09-22
DE2613943A1 (de) 1976-10-14
DE2613943B2 (enExample) 1979-07-05
FR2305990A1 (fr) 1976-10-29
ES446637A1 (es) 1977-06-01
DE2613943C3 (de) 1980-03-06
FR2305990B1 (enExample) 1980-01-25

Similar Documents

Publication Publication Date Title
JPS55148099A (en) Production of 9 alphaa hydroxyandrostendione by microorganism
CS194234B2 (en) Method of production of the bis-/dihydrixypropylamides/ of the acid 5-hydroxypropionylamino-2,4,6-troiodisophtale
GB1551829A (en) Process for the preparation of dispersions
YU314175A (en) Process for obtaining galactosidase by means of microorganisms
PT65135B (en) Process of preparing lactic acid
CS179949B2 (en) Method for production of novel d-homopregn-4-ene 3,20-diones
JPS51121511A (en) Production of vaccine based on polysaccharid adduct nucleotic acid extracted from microorganism bacterium
GR63123B (en) Preparation process of novel 1,4-diphenyl-3-pyrazolin-5-ones
JPS5254020A (en) Set for testng bacterium
GB1555791A (en) Process for the production of phophite cholides
GB1543039A (en) Process for the preparation of polyisobutene-substituted succinic anhydride
JPS55131395A (en) Production of compound by microorganism in presence of steroid
JPS526796A (en) Process for preparing polyester elastomers
HU178347B (en) Process for the production of microorganisms
CS190550B2 (en) Method of producing 6,11-dihydro-11-oxodibenz/b,e/-oxepinalkanoic acid
GB1531635A (en) Process for the recovery of 2,6-dimethylphenol
GB1521558A (en) Process for the production of o-derivatives of rho-isopropenyl phenol
GR58256B (en) Process for the production of dioxyclavulanic acid
CS191211B2 (en) Method of production of the 0,0-dimethyl-event. 0,0-diethyl-0-/2,2-dichlorvinyl/esters of the thionofosfor for acid
IE43395L (en) Dithiophosphoric acid ester dihalides.
JPS5276484A (en) Production of 33 oxobisnorcolaa1*44dienic acid by microorganism
JPS5223086A (en) Novel method of preparing 2,3- dioxopiperazine
NL181799C (nl) Werkwijze ter bereiding van een ester van 6,6,6-trihalogeen-3,3-dimethyl-4-hexeenzuur.
JPS5246064A (en) Process for preparation of novel tetrahydrofuran derivatives
IL49198A0 (en) The production of halophenols